Eye Health Aotearoa–Roche NZ Report: “Identifying Health System Constraints and Barriers for People Living with Neovascular Age-Related Macular Degeneration.”
Published by Eye Health Aotearoa
June 04, 2025
Eye Health Aotearoa and Roche NZ have released a new report highlighting major gaps in support for New Zealanders living with neovascular age-related macular degeneration (nAMD) — a leading cause of vision loss. The report reveals limited awareness, barriers to treatment access, and a lack of coordinated care.
It calls on Government to develop a National Eye Health Strategy, invest in public awareness and early detection, fund patient organisations, and improve collaboration across the health sector.
View/download the full report:
